8/5/2013 9:17 P.M. ET
Vogelsong set to face Orioles on Friday
By Chris Haft and Alex Espinoza / MLB.com
SAN FRANCISCO -- With a little less than two months remaining on the schedule, Ryan Vogelsong's season will begin again.
Having recovered from a fractured right pinkie, Vogelsong will rejoin the Giants' starting rotation Friday when he faces the Baltimore Orioles at AT&T Park.
Vogelsong's return promises to launch another chapter in his eventful professional saga. He overcame rejection from organizations in the Major Leagues and Japan to become a National League All-Star in 2011 and the Giants' leading winner in last year's postseason.
Vogelsong said Monday that facing the Orioles will culminate a rehabilitation process that reflects "everything I've been through, throughout my career. It's been 2 1/2 months of what it took for me to get here in the first place."
Vogelsong made his final Minor League injury rehab start Sunday, allowing one run and five hits in six innings for the Giants' Double-A Richmond affiliate in its 8-3 victory over New Hampshire. The right-hander allowed three runs in 15 2/3 innings in four rehab appearances, posting a 1.72 ERA.
The Giants had considered assigning Vogelsong one more Minor League tuneup, but manager Bruce Bochy said that the aftermath of Sunday's 85-pitch effort convinced the team that he was ready to return.
"More than anything, how he came out of it, how good he feels and the number of pitches he threw," Bochy said. He added that Vogelsong probably can elevate his pitch count to 100 if necessary against the Orioles.
Vogelsong said that he's throwing all of his pitches pain-free.
"I don't even think about it," he said, referring to the injury he sustained when he was hit by a pitch from Washington's Craig Stammen on May 20. Vogelsong added that he has been able to make mechanical adjustments between deliveries, just as he must do in a big league game, and he felt secure that he has honed his mental approach.
"You know that's a big thing for me," he said.
Vogelsong owns a 2-4 record with a 7.19 ERA in nine starts, though he pitched five shutout innings against Washington before his mishap.
Zito didn't suggest move to bullpen, may start again
SAN FRANCISCO -- Clarifying an article posted on sfgiants.com last Saturday, Giants left-hander Barry Zito said Monday that he never volunteered to relinquish his role in the starting rotation and take a berth in the bullpen.
Zito wanted to correct the message sent by a passage in the story stating that he admitted "a change might be necessary" to Giants manager Bruce Bochy.
"I never suggested it. Absolutely not," Zito said. "Am I happy about going to the bullpen? Certainly not. I've been a starting pitcher all my life. I feel like that's my role."
Zito reiterated that he approached Bochy after allowing four runs in 3 1/3 innings last Tuesday in Philadelphia and acknowledged that he was hurting the bullpen by not being able to pitch deep into ballgames.
"I was saying, 'I want you to keep the faith in me,'" Zito said.
The next day, Bochy informed Zito that right-hander Guillermo Moscoso would replace him as Sunday's starter against the Tampa Bay Rays, who have thrived against left-handed starters. Their record against lefties is 23-13.
Bochy told reporters in his pregame briefing Monday that he'll try to keep Zito sharp and find a spot for him to make a start, even with Ryan Vogelsong reclaiming his berth in the rotation with his scheduled start Friday against Baltimore. Vogelsong's impending return gives the Giants a full contingent of starters without Zito or Moscoso.
Asked if he believes Zito will start another game for the Giants, Bochy said, "I do, yeah."
Bochy supports efforts to end use of PEDs
SAN FRANCISCO -- The news of 13 suspensions Monday in the wake of Major League Baseball's Biogenesis investigation elicited strong opinions from many players, and Giants manager Bruce Bochy said he understands the ire of players who have competed fairly.
"It's not like it's just coming into the game," Bochy said of MLB's efforts to rid the game of PEDS. "This has been going on now for a few years and there's been testing and the fact that guys are still trying, they should be upset. It's time to end this."
"We had to go through it like most of these clubs did last year," Bochy said in reference to Melky Cabrera's 50-game suspension a year ago when he led the National League in hits.
In the days leading up to Monday's official announcement, multiple reports surfaced with names, but no Giants were listed.
"I didn't have any concerns," Bochy said.
The Giants, with a 49-61 record entering play Monday, trail the Los Angeles Dodgers by 12 games and have a tough road to the top of National League West. Perhaps the division race will be affected by the Biogenesis findings, as Padres starting shortstop Everth Cabrera was among the 13 players suspended.
Yankees third baseman Alex Rodriguez received the stiffest penalty -- a 211-game ban without pay through the end of the 2014 regular season. Rodriguez, 38, has appealed the suspension, which is to begin Thursday. His case will be heard by arbitrator Fredric Horowitz. Rodriguez's discipline, MLB said in its written announcement, is based on his use and possession of numerous forms of prohibited performance-enhancing substances, including testosterone and human growth hormone, over the course of multiple years. Rodriguez's discipline under the basic agreement is for attempting to cover up his violations of the program by engaging in a course of conduct intended to "obstruct and frustrate" the investigation.
The other players who were handed 50-game suspensions include the Padres' Cabrera, Rangers outfielder Nelson Cruz, Tigers shortstop Jhonny Peralta, Mariners catcher Jesus Montero, Yankees catcher Francisco Cervelli, Phillies reliever Antonio Bastardo and recently demoted Mets utility man Jordany Valdespin. Minor Leaguers Fernando Martinez, Jordan Norberto, Fautino de los Santos, Cesar Puello and Sergio Escalona were also suspended.
Chris Haft is a reporter for MLB.com. Alex Espinoza is a contributor to MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.